Mao Weifeng, Yi Xin, Qin Jianbing, Tian Meiling, Jin Guohua
Department of Anatomy and Neurobiology, The Jiangsu Key Laboratory of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, People's Republic of China.
Neurochem Res. 2016 Jun;41(6):1315-22. doi: 10.1007/s11064-016-1831-2. Epub 2016 Jan 22.
To investigate the effect of CXCL12 on migration of neural precursor cells after traumatic brain injury (TBI). We randomly divided 48 rats into four groups: (1) the sham group, rats were performed craniotomy only, (2) the control group, saline were injected into the ipsilateral cortex after TBI, (3) the CXCL12 group, CXCL12 were injected into the ipsilateral cortex after TBI, and (4) the CXCL12 + AMD3100 group, CXCL12 and AMD3100 were mixed together and injected into the ipsilateral cortex after TBI. At 7 days after TBI, the brain tissues were subjected to immunofluorescent double-labeled staining with the antibodies of CXCR4/DCX, MMP-2/DCX, MMP-2/GFAP, MMP-2/NeuN. Western blot assay was used to measure the protein levels of MMP-2. Compared with the control group, the number of CXCR4/DCX and MMP-2 positive cells around the injured corpus callosum area were significantly increased in the CXCL12 treatment group. The area occupied by these cells expanded and the shape changed from chain distribution to radial. CXCL12 + AMD3100 treatment significantly decreased the number and distribution area of CXCR4/DCX and MMP-2 positive cells compared with the CXCL12 treatment and control group. The DCX positive cells could not form chain or radial distribution. The protein expressions of MMP-2 had the similar change trends as the results of immunofluorescent staining. MMP-2 could be secreted by DCX, GFAP and NeuN positive cells. CXCL12/CXCR4 axis can improve the migration of the neuroblasts along the corpus callosum by stimulating the MMP-2 secretion of different types of cells.
为研究趋化因子CXCL12对创伤性脑损伤(TBI)后神经前体细胞迁移的影响。我们将48只大鼠随机分为四组:(1)假手术组,仅对大鼠进行开颅手术;(2)对照组,TBI后向同侧皮质注射生理盐水;(3)CXCL12组,TBI后向同侧皮质注射CXCL12;(4)CXCL12 + AMD3100组,TBI后将CXCL12与AMD3100混合后注射到同侧皮质。TBI后7天,用CXCR4/双皮质素(DCX)、基质金属蛋白酶-2(MMP-2)/DCX、MMP-2/胶质纤维酸性蛋白(GFAP)、MMP-2/神经元核抗原(NeuN)抗体对脑组织进行免疫荧光双标记染色。采用蛋白质免疫印迹法检测MMP-2的蛋白水平。与对照组相比,CXCL12治疗组胼胝体损伤区周围CXCR4/DCX和MMP-2阳性细胞数量显著增加。这些细胞所占区域扩大,形态从链状分布变为放射状。与CXCL12治疗组和对照组相比,CXCL12 + AMD3100治疗显著降低了CXCR4/DCX和MMP-2阳性细胞的数量和分布面积。DCX阳性细胞不能形成链状或放射状分布。MMP-2的蛋白表达与免疫荧光染色结果具有相似的变化趋势。MMP-2可由DCX、GFAP和NeuN阳性细胞分泌。CXCL12/CXCR4轴可通过刺激不同类型细胞分泌MMP-2来促进神经母细胞沿胼胝体迁移。